TY - JOUR
AU - Mahmoud, Sherif
AB - Neurocrit Care (2017) 26:182–190 DOI 10.1007/s12028-016-0300-8 ORIGINAL ARTICLE Risk of Hyponatremia in Patients with Aneurysmal Subarachnoid Hemorrhage Treated with Exogenous Vasopressin Infusion 1 1 2 1 • • • Nancy Marr Jessica Yu Demetrios J. Kutsogiannis Sherif Hanafy Mahmoud Published online: 27 September 2016 Springer Science+Business Media New York 2016 Abstract and treatment, vasopressin was associated with hypona- Background Vasopressin is one of the vasopressors used to tremia (OR 3.58, 95 % CI, 1.02–12.5, p value 0.046). augment blood pressure in subarachnoid hemorrhage Conclusions The results of the present study suggest that (SAH) patients with clinically significant vasospasm. The hyponatremia may be more common in SAH patients purpose of the present study was to determine whether the treated with exogenous vasopressin compared to those who administration of vasopressin to a population of SAH did not receive it. Serum sodium should be monitored patients was an independent predictor of developing closely when vasopressin is being used in the SAH popu- hyponatremia. lation. Further studies are needed to confirm the effect of Methods A retrospective review on the health records of exogenous vasopressin on serum sodium levels in SAH 106 patients admitted to the University of Alberta Hospital populations. Neurosciences ICU, 
TI - Risk of Hyponatremia in Patients with Aneurysmal Subarachnoid Hemorrhage Treated with Exogenous Vasopressin Infusion
JF - Neurocritical Care
DO - 10.1007/s12028-016-0300-8
DA - 2016-09-27
UR - https://www.deepdyve.com/lp/springer-journals/risk-of-hyponatremia-in-patients-with-aneurysmal-subarachnoid-veGnslTmi7
SP - 182
EP - 190
VL - 26
IS - 2
DP - DeepDyve
ER -